Source comparison
The Core Distinction: Hyperplasia vs Hypertrophy in Muscle Growth
Most anabolic agents. Testosterone, trenbolone, nandrolone. Work exclusively through hypertrophy: they increase the size of existing muscle cells by enhancing protein synthesis and reducing protein degradation. IGF-1 LR3 operates through both mechanisms simult
This comparison does not assign a generated winner or score.
- Most anabolic agents. Testosterone, trenbolone, nandrolone. Work exclusively through hypertrophy: they increase the size of existing muscle cells by enhancing protein synthesis and reducing protein degradation. IGF-1 LR3 operates through both mechanisms simultaneously. Hyperplasia refers to satellite cell activation, proliferation, and fusion into existing myofibers. Creating entirely new contractile units. Hypertrophy increases the cross-sectional area of muscle fibers by accumulating additional myofibrils and sarcoplasmic proteins.
- The practical distinction matters because hyperplasia creates a permanent structural change: once new muscle cells form and integrate into existing tissue, they remain even after IGF-1 LR3 administration stops. Hypertrophy-driven gains, by contrast, are more reversible. When anabolic signaling drops, muscle size regresses toward genetic baseline. Research from Texas A&M University demonstrated that satellite cell-derived nuclei persist for at least 15 years post-training stimulus, supporting the concept of 'muscle memory'. A phenomenon hyperplasia makes biochemically real.
- IGF-1 LR3 activates the PI3K/Akt/mTOR pathway more potently than native IGF-1 because its extended half-life sustains receptor occupancy. This drives ribosomal biogenesis, increases translation efficiency, and suppresses FOXO-mediated atrophy signaling. Simultaneously, the peptide activates quiescent satellite cells located between the basal lamina and sarcolemma of muscle fibers. These cells proliferate, differentiate into myoblasts, and fuse with damaged or growing fibers. A 2021 study in Muscle & Nerve found IGF-1 LR3 increased myonuclear domain expansion by 28% compared to resistance training alone.